Lixumistat (acetate) - HY-136093A
Nur noch %1 verfügbar
Catalog #
HY-136093A
Ab
98,00 €
Lixumistat (IM156; HL156A; HL271) acetate, a chemical derivative of Metformin (HY-B0627), is a potent and orally active AMPK activator that increases AMPK phosphorylation. Lixumistat (acetate) attenuates aging-associated cognitive impairment in animal model[1][2]. Lixumistat (acetate) is a potent oxidative phosphorylation (OXPHOS) inhibitor which can be used for the research of solid tumors[3].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-136093A/Lixumistat-acetate-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | Neuroscience-Neuromodulation |
| Alternative Names | IM156; HL156A; HL271 (acetate) |
| CAS | 1422365-94-3 |
| Storage | 4°C (Powder, sealed storage, away from moisture and light) |
| MWT | 375.35 |
| Solubility | DMSO : 50 mg/mL (ultrasonic;warming;heat to 60°C) |
| Clinical Information | Phase 1 |
| Target | AMPK;Oxidative Phosphorylation |
| Application: | Neuroscience-Neuromodulation |
|---|